In this KevinMD podcast/article, Dr. Gregory Jasani, an emergency medicine physician in an inner-city, discusses his experiences treating COVID-19 patients and his thoughts surrounding the current mask mandates across the country. In his experience, wearing a mask is not about a person’s civil liberties, but rather the numbers game when you work in healthcare.

According to an international task force at the virtual PAINWeek meeting, chronic pain patients can be treated with medical cannabis following one of three protocols based on patient characteristics. The recommendations are timely considering the limited clinician knowledge about medical cannabis treatment and the opioid crisis.

Our friends at the Mayo Clinic have provided this excellent resource to track the data you need to help protect yourself, your patients, your friends, your family, and anyone else you may come in contact with during this unprecedented time. Trends for the US are simple to access and see, whether they are new cases, positive taste rates, total new cases, or others.

In this Original Investigation from JAMA Oncology, the authors attempt to discover whether increased coffee consumption is associated with improved survival in patients with advanced or metastatic colorectal cancer. Overall survival (OS) and progression-free survival (PFS) were the main outcomes and measures, and both decaffeinated and caffeinated coffee were studied.

In this opinion piece from MedPage Today, the authors state “anti-psychiatry” was “formerly a healthy corrective, but the movement now distracts from real problems and actively hurts people, existing as a disorganized entity outside of mainstream medicine, largely propagated on social media and in non-peer-reviewed sources…that evade scientific dialogue and critique.”

The NCI sponsors and funds the consortium, a multidisciplinary cooperative research organization devoted to the study of correlative tumor biology and new therapies for children with primary central nervous system tumors. New members are chosen through a competitive process based on several characteristics, including clinical trial infrastructure and expertise in basic and translational science.